Showing results (321-330 of 339) with videos related to
Sort By:
Pageof 34
La Clinica Terapeutica|October 9, 2021
Risk Management for a Legally Valid Informed ConsentF Guerra, P La Rosa, F Guerra, et al.Biogerontology|May 3, 2025
Lifestyle, environment and other major determinants of frailty in older adults: a population-based study from the UK BiobankAli Hemadeh, Carlota Lema-Arranz, Stefano Bonassi, et al.Bioorganic & Medicinal Chemistry|March 14, 2007
Synthesis and preliminary pharmacological evaluation of the four stereoisomers of (2S)-2-(2'-phosphono-3'-phenylcyclopropyl)glycine, the first class of 3'-substituted trans C1'-2'-2-(2'-phosphonocyclopropyl)glycinesMaura Marinozzi, Michaela Serpi, Laura Amori, et al.La Clinica Terapeutica|April 4, 2024
Radiomic Application for Head and Neck Squamocellular Tumor: Systematic ReviewD Messineo, F Massaro, P Izzo, et al.The Journal of Infectious Diseases|July 18, 2006
Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipientsMaurizia Debiaggi, Filippo Canducci, Michela Sampaolo, et al.Clinical Nuclear Medicine|March 30, 2022
Role of Dynamic Parameters of 18F-DOPA PET/CT in Pediatric GliomasFrancesco Fiz, Fabiano Bini, Edoardo Gabriele, et al.Journal of the American Society of Nephrology : JASN|January 19, 2017
Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GNMaria Chiara Marinozzi, Lubka T Roumenina, Sophie Chauvet, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 28, 2025
[18F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patientsMatteo Bauckneht, Giovanni Pasini, Tania Di Raimondo, et al.Frontiers in Immunology|October 19, 2018
Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 GlomerulopathySophie Chauvet, Lubka T Roumenina, Pierre Aucouturier, et al.Journal of the American Society of Nephrology : JASN|March 22, 2014
Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?Maria Chiara Marinozzi, Laura Vergoz, Tania Rybkine, et al.Pageof 34